Immunocore Holdings annual operating expenses
2021
2022
2023
2024
2025
Immunocore Holdings Operating Expenses Growth & History (IMCR)
Immunocore Holdings's operating expenses was $440.3M for fiscal 2025.
View full Immunocore Holdings company overviewImmunocore Holdings annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $440.3M | $62.4M | +16.50% |
| 2024 | 2024-12-31 | $377.9M | $69.9M | +22.69% |
| 2023 | 2023-12-31 | $308.0M | $83.1M | +36.92% |
| 2022 | 2022-12-31 | $225.0M | $46.3M | +25.92% |
| 2021 | 2021-12-31 | $178.7M | — | — |
Immunocore Holdings quarterly operating expenses
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $117.8M | $6.0M | +5.40% |
| Q1 2026 | 2026-03-31 | $99.0M | $2.3M | +2.38% |
| Q4 2025 | 2025-12-31 | $121.5M | $18.3M | +17.73% |
| Q3 2025 | 2025-09-30 | $110.4M | $22.0M | +24.97% |
| Q2 2025 | 2025-06-30 | $111.8M | $22.1M | +24.62% |
| Q1 2025 | 2025-03-31 | $96.7M | −$80,000 | −0.08% |
| Q4 2024 | 2024-12-31 | $103.2M | $16.2M | +18.57% |
| Q3 2024 | 2024-09-30 | $88.3M | $9.6M | +12.18% |
| Q2 2024 | 2024-06-30 | $89.7M | $16.5M | +22.61% |
| Q1 2024 | 2024-03-31 | $96.7M | $27.6M | +39.93% |
| Q4 2023 | 2023-12-31 | $87.0M | — | — |
| Q3 2023 | 2023-09-30 | $78.7M | — | — |
| Q2 2023 | 2023-06-30 | $73.2M | — | — |
| Q1 2023 | 2023-03-31 | $69.1M | — | — |
Immunocore Holdings operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Immunocore Holdings's operating expenses increased from $178.7M to $440.3M, a change of $261.6M. The latest reported quarter, Q2 2026, shows $117.8M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Immunocore Holdings source filings ↗